上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC 2019-03-26 08:24
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
WuXi Biologics Continues to Deliver Record Results 2019-03-18 22:25
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics 2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics 2019-02-19 08:21
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership 2019-02-12 08:04
WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership 2018-12-19 20:16
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development 2018-12-13 07:30
WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity 2018-12-12 08:08
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 15:00
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 09:47
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics 2018-12-10 10:21
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:20
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-12-05 23:29
WuXi Biologics Selected as Forbes Asia's Best Under A Billion 2018 2018-11-29 21:28
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies 2018-11-28 19:44
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai 2018-11-22 14:31
1 6 7 8 9 10